
#485 — The New Science of Cancer
Making Sense with Sam Harris
00:00
Prevention Studies Are Harder Because You Prove Nonoccurrence
- Prevention trials are scientifically harder because you must prove something did not happen, requiring long follow-ups and no good universal surrogate biomarker for future cancer.
- Mukherjee contrasts this with heart disease where cholesterol or blood pressure serve as actionable surrogates, explaining why cancer prevention studies are prolonged and costly.
Play episode from 05:44
Transcript


